APO Research
Talk to an analyst

APO RESEARCH · REPORT

BCG Vaccine

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Selected research

Market Structure

Global BCG Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026189 pages

Choose your research edition.

Industry ResearchBCG Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal BCG Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal BCG Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BCG Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal BCG Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.

This report provides an overview of the global BCG Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of BCG Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents BCG Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the BCG Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

BCG Vaccine Segment by Company

Merck

Sanofi Pasteur

Japan BCG Lab

China National Biotec

Serum Institute of India

Intervax

GSBPL

BCG Vaccine Segment by Type

Immune BCG

Therapy BCG

BCG Vaccine Segment by Application

Hospitals

Clinics

Others

BCG Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BCG Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the BCG Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of BCG Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of BCG Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. BCG Vaccine Industry Trends Table 2. BCG Vaccine Industry Drivers Table 3. BCG Vaccine Industry Opportunities and Challenges Table 4. BCG Vaccine Industry Restraints Table 5. Global BCG Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global BCG Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global BCG Vaccine Sales by Manufacturers (MT) & (2021-2026) Table 8. Global BCG Vaccine Sales Market Share by Manufacturers Table 9. Global BCG Vaccine Average Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global BCG Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global BCG Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global BCG Vaccine Manufacturers, Product Type & Application Table 13. Global BCG Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global BCG Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Immune BCG Table 17. Major Manufacturers of Therapy BCG Table 18. Global BCG Vaccine Sales by Type 2021 VS 2025 VS 2032 (MT) Table 19. Global BCG Vaccine Sales by Type (2021-2026) & (MT) Table 20. Global BCG Vaccine Sales by Type (2027-2032) & (MT) Table 21. Global BCG Vaccine Sales Market Share by Type (2021-2026) Table 22. Global BCG Vaccine Sales Market Share by Type (2027-2032) Table 23. Global BCG Vaccine Revenue by Type 2021 VS 2025 VS 2032 (MT) Table 24. Global BCG Vaccine Revenue by Type (2021-2026) & (MT) Table 25. Global BCG Vaccine Revenue by Type (2027-2032) & (MT) Table 26. Global BCG Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global BCG Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Others Table 31. Global BCG Vaccine Sales by Application 2021 VS 2025 VS 2032 (MT) Table 32. Global BCG Vaccine Sales by Application (2021-2026) & (MT) Table 33. Global BCG Vaccine Sales by Application (2027-2032) & (MT) Table 34. Global BCG Vaccine Sales Market Share by Application (2021-2026) Table 35. Global BCG Vaccine Sales Market Share by Application (2027-2032) Table 36. Global BCG Vaccine Revenue by Application 2021 VS 2025 VS 2032 (MT) Table 37. Global BCG Vaccine Revenue by Application (2021-2026) & (MT) Table 38. Global BCG Vaccine Revenue by Application (2027-2032) & (MT) Table 39. Global BCG Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global BCG Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global BCG Vaccine Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 42. Global BCG Vaccine Sales by Region (2021-2026) & (MT) Table 43. Global BCG Vaccine Sales Market Share by Region (2021-2026) Table 44. Global BCG Vaccine Sales Forecasted by Region (2027-2032) & (MT) Table 45. Global BCG Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America BCG Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 47. North America BCG Vaccine Sales by Country (2021-2026) & (MT) Table 48. North America BCG Vaccine Sales by Country (2027-2032) & (MT) Table 49. Europe BCG Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 50. Europe BCG Vaccine Sales by Country (2021-2026) & (MT) Table 51. Europe BCG Vaccine Sales by Country (2027-2032) & (MT) Table 52. Asia Pacific BCG Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 53. Asia Pacific BCG Vaccine Sales by Country (2021-2026) & (MT) Table 54. Asia Pacific BCG Vaccine Sales by Country (2027-2032) & (MT) Table 55. South America, Middle East and Africa BCG Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 56. South America, Middle East and Africa BCG Vaccine Sales by Country (2021-2026) & (MT) Table 57. South America, Middle East and Africa BCG Vaccine Sales by Country (2027-2032) & (MT) Table 58. Global BCG Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global BCG Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global BCG Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global BCG Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global BCG Vaccine Revenue Market Share by Region (2027-2032) Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck BCG Vaccine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merck BCG Vaccine Product Portfolio Table 67. Merck Recent Development Table 68. Sanofi Pasteur Company Information Table 69. Sanofi Pasteur Business Overview Table 70. Sanofi Pasteur BCG Vaccine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sanofi Pasteur BCG Vaccine Product Portfolio Table 72. Sanofi Pasteur Recent Development Table 73. Japan BCG Lab Company Information Table 74. Japan BCG Lab Business Overview Table 75. Japan BCG Lab BCG Vaccine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Japan BCG Lab BCG Vaccine Product Portfolio Table 77. Japan BCG Lab Recent Development Table 78. China National Biotec Company Information Table 79. China National Biotec Business Overview Table 80. China National Biotec BCG Vaccine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. China National Biotec BCG Vaccine Product Portfolio Table 82. China National Biotec Recent Development Table 83. Serum Institute of India Company Information Table 84. Serum Institute of India Business Overview Table 85. Serum Institute of India BCG Vaccine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Serum Institute of India BCG Vaccine Product Portfolio Table 87. Serum Institute of India Recent Development Table 88. Intervax Company Information Table 89. Intervax Business Overview Table 90. Intervax BCG Vaccine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Intervax BCG Vaccine Product Portfolio Table 92. Intervax Recent Development Table 93. GSBPL Company Information Table 94. GSBPL Business Overview Table 95. GSBPL BCG Vaccine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. GSBPL BCG Vaccine Product Portfolio Table 97. GSBPL Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. BCG Vaccine Distributors List Table 101. BCG Vaccine Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. BCG Vaccine Product Image Figure 2. Global BCG Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BCG Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global BCG Vaccine Sales (2021-2032) & (MT) Figure 5. Global BCG Vaccine Average Price (USD/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 BCG Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Immune BCG Image Figure 9. Therapy BCG Image Figure 10. Global BCG Vaccine Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 11. Global BCG Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global BCG Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global BCG Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (MT) Figure 14. Global BCG Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global BCG Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Clinics Image Figure 18. Others Image Figure 19. Global BCG Vaccine Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 20. Global BCG Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global BCG Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global BCG Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (MT) Figure 23. Global BCG Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global BCG Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 26. North America BCG Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 28. Canada BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 29. Mexico BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 30. Europe BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 31. Europe BCG Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 33. France BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 34. U.K. BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 35. Italy BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 36. Netherlands BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 37. Asia Pacific BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 38. Asia Pacific BCG Vaccine Sales Market Share by Country (2021-2032) Figure 39. China BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 40. Japan BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 41. South Korea BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 42. Southeast Asia BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 43. India BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 44. Australia BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 45. South America, Middle East and Africa BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 46. South America, Middle East and Africa BCG Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 48. South Africa BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 49. Saudi Arabia BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 50. Turkey BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 51. Argentina BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 52. UAE BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 53. Egypt BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 54. Chile BCG Vaccine Sales and Growth Rate (2021-2032) & (MT) Figure 55. Global BCG Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global BCG Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America BCG Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America BCG Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe BCG Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe BCG Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific BCG Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific BCG Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa BCG Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa BCG Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. BCG Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. BCG Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Immune BCG
  • Therapy BCG
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Merck
  • Sanofi Pasteur
  • Japan BCG Lab
  • China National Biotec
  • Serum Institute of India
  • Intervax
  • GSBPL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global BCG Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global BCG Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global BCG Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global BCG Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global BCG Vaccine Market Dynamics
  1. 2.1 BCG Vaccine Industry Trends
  2. 2.2 BCG Vaccine Industry Drivers
  3. 2.3 BCG Vaccine Industry Opportunities and Challenges
  4. 2.4 BCG Vaccine Industry Restraints
3 BCG Vaccine Market by Manufacturers
  1. 3.1 Global BCG Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global BCG Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global BCG Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global BCG Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global BCG Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global BCG Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global BCG Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global BCG Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 BCG Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 BCG Vaccine Tier 1, Tier 2, and Tier 3
4 BCG Vaccine Market by Type
  1. 4.1 BCG Vaccine Type Introduction
  2. 4.1.1 Immune BCG
  3. 4.1.2 Therapy BCG
  4. 4.2 Global BCG Vaccine Sales by Type
  5. 4.2.1 Global BCG Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global BCG Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global BCG Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global BCG Vaccine Revenue by Type
  9. 4.3.1 Global BCG Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global BCG Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global BCG Vaccine Revenue Market Share by Type (2021-2032)
5 BCG Vaccine Market by Application
  1. 5.1 BCG Vaccine Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global BCG Vaccine Sales by Application
  6. 5.2.1 Global BCG Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global BCG Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global BCG Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global BCG Vaccine Revenue by Application
  10. 5.3.1 Global BCG Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global BCG Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global BCG Vaccine Revenue Market Share by Application (2021-2032)
6 Global BCG Vaccine Sales by Region
  1. 6.1 Global BCG Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global BCG Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global BCG Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global BCG Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America BCG Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America BCG Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe BCG Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe BCG Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific BCG Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific BCG Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa BCG Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa BCG Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global BCG Vaccine Revenue by Region
  1. 7.1 Global BCG Vaccine Revenue by Region
  2. 7.1.1 Global BCG Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global BCG Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global BCG Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global BCG Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America BCG Vaccine Revenue (2021-2032)
  8. 7.2.2 North America BCG Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe BCG Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe BCG Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific BCG Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific BCG Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa BCG Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa BCG Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck BCG Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck BCG Vaccine Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Sanofi Pasteur
  8. 8.2.1 Sanofi Pasteur Company Information
  9. 8.2.2 Sanofi Pasteur Business Overview
  10. 8.2.3 Sanofi Pasteur BCG Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Pasteur BCG Vaccine Product Portfolio
  12. 8.2.5 Sanofi Pasteur Recent Developments
  13. 8.3 Japan BCG Lab
  14. 8.3.1 Japan BCG Lab Company Information
  15. 8.3.2 Japan BCG Lab Business Overview
  16. 8.3.3 Japan BCG Lab BCG Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Japan BCG Lab BCG Vaccine Product Portfolio
  18. 8.3.5 Japan BCG Lab Recent Developments
  19. 8.4 China National Biotec
  20. 8.4.1 China National Biotec Company Information
  21. 8.4.2 China National Biotec Business Overview
  22. 8.4.3 China National Biotec BCG Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 China National Biotec BCG Vaccine Product Portfolio
  24. 8.4.5 China National Biotec Recent Developments
  25. 8.5 Serum Institute of India
  26. 8.5.1 Serum Institute of India Company Information
  27. 8.5.2 Serum Institute of India Business Overview
  28. 8.5.3 Serum Institute of India BCG Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Serum Institute of India BCG Vaccine Product Portfolio
  30. 8.5.5 Serum Institute of India Recent Developments
  31. 8.6 Intervax
  32. 8.6.1 Intervax Company Information
  33. 8.6.2 Intervax Business Overview
  34. 8.6.3 Intervax BCG Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intervax BCG Vaccine Product Portfolio
  36. 8.6.5 Intervax Recent Developments
  37. 8.7 GSBPL
  38. 8.7.1 GSBPL Company Information
  39. 8.7.2 GSBPL Business Overview
  40. 8.7.3 GSBPL BCG Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GSBPL BCG Vaccine Product Portfolio
  42. 8.7.5 GSBPL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 BCG Vaccine Value Chain Analysis
  2. 9.1.1 BCG Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 BCG Vaccine Production Mode & Process
  6. 9.2 BCG Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 BCG Vaccine Distributors
  9. 9.2.3 BCG Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst